Launchit Solutions and Privacy Horizon Partner to Help Canadian Health Tech Companies Build, Govern, and Scale with Confidence

Launchit Solutions and Privacy Horizon announced a strategic partnership that gives Canadian health tech startups and scale-ups coordinated access to healthcare software development, Canadian cloud infrastructure, data governance, privacy and security readiness, and responsible AI governance.
AI used to help improve lung cancer biopsies

Node AI, a Hamilton-based medical AI company, has developed a real-time decision-support platform designed to assist clinicians performing lung cancer biopsies.
For Canadian femtech, women’s autonomy is part of the business model

Every founder has an origin story. There’s one kind that may resonate with many Canadian femtech founders: interacting with a healthcare and benefits system that’s not designed to serve her at all.
AI-powered trial at Toronto General aims to improve accuracy of lung cancer biopsies

University Health Network and Hamilton-based NodeAI have launched a clinical trial testing an AI platform designed to improve the accuracy of EBUS lung cancer biopsies in real time.
Scispot closes $8-million USD Series A to become the operating layer for life sciences labs

Kitchener-Waterloo-based Scispot has secured $8 million USD in Series A funding to bring its platform to more companies.
Stoked Bio announces the closing of seed financing round

Stoked Bio Inc. announces the closing of an oversubscribed $2.5M Seed round to advance pipeline of novel therapeutics for conditions of high unmet medical needs.
NerView Surgical wins Falcons’ Fortunes 2026 for its precise nerve visualization technology making cancer surgeries safer for patients

Mann Parikh, Founder and CEO of NerView Surgical, won the $100,000 Ernsting Entrepreneurship award at FACIT’s Falcons’ Fortunes 2026 pitch competition for the real-time nerve visualization system his team is developing.
McMaster researcher awarded more than $2M from Weston Family Foundation to advance precision antibiotic for IBD toward human trials

A McMaster University researcher receives $2M+ from the Weston Family Foundation to advance a new precision antibiotic for IBD toward clinical trials.
FluidAI Medical announces an acquisition deal with Emmetros Limited

FluidAI announces the acquisition of Emmetros, enhancing patient engagement with Stream Inara™ and innovative AI solutions.
Researchers discover new antibiotic for IBD and AI correctly predicts how it works

Learn how researchers from Stoked Bio are discovering new antibiotics for IBD using AI-based drug discovery solutions.